Hormone Replacement Therapy (HRT) Market By Product, End User and Source Type - Global Industry Analysis & Forecast to 2027

Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101565

Hormone Replacement Therapy (HRT) Market By Product (HGH Replacement Therapy, Estrogen Replacement Therapy, Thyroid Replacement Therapy, Other) Route Of Administration (Parenteral, Oral, Transdermal, Others) Type Of Disease (Hypothyroidism, Growth Hormone Deficiency, Menopause, Male Hypogonadism, Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Hormone Replacement Therapy (HRT) Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Rising frequencies of hormonal lopsidedness issue and expanding aged and the neonatal populace experiencing these sicknesses are foreseen to advance development.  Developing interest of HRT is driven by the existence of routinely observed details, technological progression in the field of drug delivery frameworks, and expanding awareness among patients.  Menopausal females frame the biggest segment influencing the market and subsequently, rising female populace between the age gathering of 45 to 59 and expanding scope of the menopausal window are anticipated to push development.

Drivers and Restraints

 Estrogen captures the biggest share of the market and contributed over 50.0% of the revenue in 2017. Parenteral hormone replacement therapy holds the biggest segment and is anticipated to encounter beneficial growth over the forecast period. Menopause-based hormone replacement is foreseen to be the fastest developing over the upcoming years.

Regional Insights

The Asia-Pacific region is anticipated to encounter the fastest development over the forecast period. Rising awareness and increasing concentration of healthcare providers on reducing hormonal deficiencies are anticipated to bolster development.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Novartis
  • Mylan Laboratories
  • Amgen
  • Bayer
  • Wyeth
  • Abbott Laboratories
  • Pfizer
  • Merck & Co.
  • Novo Nordisk

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Hormone Replacement Therapy (HRT) Market, By Product, Estimates and Forecast, 2017-2027($Billion)

o    HGH Replacement Therapy

o    Estrogen Replacement Therapy

o    Thyroid Replacement Therapy

o    Other

·         Hormone Replacement Therapy (HRT) Market, By Route Of Administration, Estimates and Forecast, 2017-2027($Billion)

o    Parenteral

o    Oral

o    Transdermal

o    Others

·         Hormone Replacement Therapy (HRT) Market, By Type Of Disease, Estimates and Forecast, 2017-2027($Billion)

o    Hypothyroidism

o    Growth Hormone Deficiency

o    Menopause

o    Male Hypogonadism

o    Others

·         Hormone Replacement Therapy (HRT) Market, By Region, Estimates and Forecast, 2017-2027($Billion)

o    North America

§  North America Hormone Replacement Therapy (HRT) Market, By Country

o    U.S. Hormone Replacement Therapy (HRT) Market

o    Canada Hormone Replacement Therapy (HRT) Market

o    Mexico Hormone Replacement Therapy (HRT) Market

o    Europe

§  Europe Hormone Replacement Therapy (HRT) Market, By Country

o    Germany Hormone Replacement Therapy (HRT) Market

o    UK Hormone Replacement Therapy (HRT) Market

o    France Hormone Replacement Therapy (HRT) Market

o    Russia Hormone Replacement Therapy (HRT) Market

o    Italy Hormone Replacement Therapy (HRT) Market

o    Rest of Europe Hormone Replacement Therapy (HRT) Market

o    Asia-Pacific

§  Asia-Pacific Hormone Replacement Therapy (HRT) Market, By Country

o    China Hormone Replacement Therapy (HRT) Market

o    Japan Hormone Replacement Therapy (HRT) Market

o    South Korea Hormone Replacement Therapy (HRT) Market

o    India Hormone Replacement Therapy (HRT) Market

o    Southeast Asia Hormone Replacement Therapy (HRT) Market

o    Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Market

o    South America

§  South America Hormone Replacement Therapy (HRT) Market

o    Brazil Hormone Replacement Therapy (HRT) Market

o    Argentina Hormone Replacement Therapy (HRT) Market

o    Columbia Hormone Replacement Therapy (HRT) Market

o    Rest of South America Hormone Replacement Therapy (HRT) Market

o    Middle East and Africa

§  Middle East and Africa Hormone Replacement Therapy (HRT) Market

o    Saudi Arabia Hormone Replacement Therapy (HRT) Market

o    UAE Hormone Replacement Therapy (HRT) Market

o    Egypt Hormone Replacement Therapy (HRT) Market

o    Nigeria Hormone Replacement Therapy (HRT) Market

o    South Africa Hormone Replacement Therapy (HRT) Market

o    Rest of MEA Hormone Replacement Therapy (HRT) Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Hormone Replacement Therapy (HRT) Market, By Product

5.1.     Introduction

5.2.     Global Hormone Replacement Therapy (HRT) Revenue and Market Share by Product  (2017-2027)

5.2.1.  Global Hormone Replacement Therapy (HRT) Revenue and Revenue Share by Product  (2017-2027)

5.3.     HGH Replacement Therapy

5.3.1.  Global HGH Replacement Therapy Revenue and Growth Rate (2017-2027)

5.4.     Estrogen Replacement Therapy

5.4.1.  Global Estrogen Replacement Therapy Revenue and Growth Rate (2017-2027)

5.5.     Thyroid Replacement Therapy

5.5.1.  Global Thyroid Replacement Therapy Revenue and Growth Rate (2017-2027)

5.6.     Other

5.6.1.  Global Other Revenue and Growth Rate (2017-2027)

6.       Hormone Replacement Therapy (HRT) Market, By Route Of Administration

6.1.     Introduction

6.2.     Global Hormone Replacement Therapy (HRT) Revenue and Market Share by Route Of Administration (2017-2027)

6.2.1.  Global Hormone Replacement Therapy (HRT) Revenue and Revenue Share by Route Of Administration (2017-2027)

6.3.     Parenteral

6.3.1.  Global Parenteral Revenue and Growth Rate (2017-2027)

6.4.     Oral

6.4.1.  Global Oral Revenue and Growth Rate (2017-2027)

6.5.     Transdermal

6.5.1.  Global Transdermal Revenue and Growth Rate (2017-2027)

6.6.     Others

6.6.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Hormone Replacement Therapy (HRT) Market, By Type Of Disease

7.1.     Introduction

7.2.     Global Hormone Replacement Therapy (HRT) Revenue and Market Share by Type Of Disease (2017-2027)

7.2.1.  Global Hormone Replacement Therapy (HRT) Revenue and Revenue Share by Type Of Disease (2017-2027)

7.3.     Hypothyroidism

7.3.1.  Global Hypothyroidism Revenue and Growth Rate (2017-2027)

7.4.     Growth Hormone Deficiency

7.4.1.  Global Growth Hormone Deficiency Revenue and Growth Rate (2017-2027)

7.5.     Menopause

7.5.1.  Global Menopause Revenue and Growth Rate (2017-2027)

7.6.     Male Hypogonadism

7.6.1.  Global Male Hypogonadism Revenue and Growth Rate (2017-2027)

7.7.     Others

7.7.1.  Global Others Revenue and Growth Rate (2017-2027)

8.       Hormone Replacement Therapy (HRT) Market, By Region

8.1.     Introduction

8.2.     Global Hormone Replacement Therapy (HRT) Revenue and Market Share by Regions

8.2.1.  Global Hormone Replacement Therapy (HRT) Revenue by Regions (2017-2027)

8.3.     North America Hormone Replacement Therapy (HRT) by Countries

8.3.1.  North America Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2027)

8.3.2.  North America Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2027)

8.3.3.  United States

8.3.3.1.  United States Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.4.  Canada

8.3.4.1.  Canada Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5.  Mexico

8.3.5.1.  Mexico Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.     Europe Hormone Replacement Therapy (HRT) by Countries

8.4.1.  Europe Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2027)

8.4.2.  Europe Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2027)

8.4.3.  Germany

8.4.3.1.  Germany Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.4.  France

8.4.4.1.  France Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5.  UK

8.4.5.1.  UK Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  Russia

8.4.6.1.  Russia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  Italy

8.4.7.1.  Italy Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.     Asia-Pacific Hormone Replacement Therapy (HRT) by Countries

8.5.1.  Asia-Pacific Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2027)

8.5.3.  China

8.5.3.1.  China Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.4.  Japan

8.5.4.1.  Japan Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.  Korea

8.5.5.1.  Korea Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.  India

8.5.6.1.  India Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.     South America Hormone Replacement Therapy (HRT) by Countries

8.6.1.  South America Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2027)

8.6.2.  South America Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2027)

8.6.3.  Brazil

8.6.3.1.  Brazil Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.4.  Argentina

8.6.4.1.  Argentina Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5.  Columbia

8.6.5.1.  Columbia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.     Middle East and Africa Hormone Replacement Therapy (HRT) by Countries

8.7.1.  Middle East and Africa Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2027)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5.  Egypt

8.7.5.1.  Egypt Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  South Africa

8.7.7.1.  South Africa Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  Turkey

8.7.8.1.  Turkey Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.     Novartis

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Mylan Laboratories

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     Amgen

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Bayer

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Wyeth

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Abbott Laboratories

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Pfizer

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     Merck & Co.

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Novo Nordisk

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

9.10. Eli Lily

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.       Revenue and Market Share

10.    Global Hormone Replacement Therapy (HRT) Market Competition, by Manufacturer

10.1. Global Hormone Replacement Therapy (HRT) Revenue and Market Share by Manufacturer (2017-2017)

10.2. Global Hormone Replacement Therapy (HRT) Price By Region (2017-2017)

10.3. Top 5 Hormone Replacement Therapy (HRT) Manufacturer Market Share

10.4. Market Competition Trend

11.    Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.1. Global Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2027)

11.2. Hormone Replacement Therapy (HRT) Market Forecast by Regions (2017-2027)

11.2.1.      North America Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.1.1. United States Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.1.2. Canada Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.1.3. Mexico Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.2.      Europe Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.2.1. Germany Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.2.2. France Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.2.3. UK Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.2.4. Russia Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.2.5. Italy Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.2.6. Rest of Europe Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.3.      Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.3.1. China Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.3.2. Japan Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.3.3. Korea Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.3.4. India Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.3.5. Southeast Asia Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.3.6. Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.4.      South America Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.4.1. Brazil Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.4.2. Argentina Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.4.3. Columbia Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.4.4. Rest of South America Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.      Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.1. Saudi Arabia Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.2. United Arab Emirates Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.3. Egypt Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.4. Nigeria Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.5. South Africa Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.6. Turkey Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.2.5.7. Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecast (2017-2027)

11.3. Hormone Replacement Therapy (HRT) Market Forecast by Product  (2017-2027)

11.3.1.      Hormone Replacement Therapy (HRT) Forecast by Product  (2017-2027)

11.3.2.      Hormone Replacement Therapy (HRT) Market Share Forecast by Product  (2017-2027)

11.4. Hormone Replacement Therapy (HRT) Market Forecast by Route Of Administration (2017-2027)

11.4.1.      Hormone Replacement Therapy (HRT) Forecast by Route Of Administration (2017-2027)

11.4.2.      Hormone Replacement Therapy (HRT) Market Share Forecast by Route Of Administration (2017-2027)

11.5. Hormone Replacement Therapy (HRT) Market Forecast by Type Of Disease (2017-2027)

11.5.1.      Hormone Replacement Therapy (HRT) Forecast by Type Of Disease (2017-2027)

11.5.2.      Hormone Replacement Therapy (HRT) Market Share Forecast by Type Of Disease (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Hormone Replacement Therapy (HRT) Revenue and Revenue Share by Product (2017-2018)
Figure Global HGH Replacement Therapy Revenue and Growth Rate (2017-2018)
Figure Global Estrogen Replacement Therapy Revenue and Growth Rate (2017-2018)
Figure Global Thyroid Replacement Therapy Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Hormone Replacement Therapy (HRT) Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Parenteral Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Figure Global Transdermal Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Hormone Replacement Therapy (HRT) Revenue and Revenue Share by Type Of Disease (2017-2018)
Figure Global Hypothyroidism Revenue and Growth Rate (2017-2018)
Figure Global Growth Hormone Deficiency Revenue and Growth Rate (2017-2018)
Figure Global Menopause Revenue and Growth Rate (2017-2018)
Figure Global Male Hypogonadism Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Hormone Replacement Therapy (HRT) Revenue by Regions (2017-2018)
Figure North America Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure North America Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2018)
Figure North America Hormone Replacement Therapy (HRT) by Countries (2017-2018)
Figure North America Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2018)
Figure United States Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure United States Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Canada Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Mexico Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Europe Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2018)
Figure Europe Hormone Replacement Therapy (HRT) by Countries (2017-2018)
Figure Europe Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2018)
Figure Germany Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Germany Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure France Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure UK Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Russia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Italy Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Rest of Europe Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Asia-Pacific Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Hormone Replacement Therapy (HRT) by Countries (2017-2018)
Figure Asia-Pacific Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2018)
Figure China Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure China Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Japan Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Korea Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure India Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Southeast Asia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure South America Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2018)
Figure South America Hormone Replacement Therapy (HRT) by Countries (2017-2018)
Figure South America Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Brazil Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Argentina Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Columbia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Rest of South America Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Middle East and Africa Hormone Replacement Therapy (HRT) Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Hormone Replacement Therapy (HRT) by Countries (2017-2018)
Figure Middle East and Africa Hormone Replacement Therapy (HRT) Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Saudi Arabia Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure United Arab Emirates Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Egypt Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Nigeria Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure South Africa Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Turkey Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2017-2018)
Table Novartis Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mylan Laboratories Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Amgen Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Wyeth Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co. Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novo Nordisk Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eli Lily Hormone Replacement Therapy (HRT) Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Hormone Replacement Therapy (HRT) Market Share by Manufacturer
Figure Global Hormone Replacement Therapy (HRT) Revenue and Market Share by Manufacturer
Table Global Hormone Replacement Therapy (HRT) Price by Region (2017-2017)
Figure Top 5 Hormone Replacement Therapy (HRT) Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Hormone Replacement Therapy (HRT) Revenue (Millions USD) and Growth Rate (2018-2025)
Table Hormone Replacement Therapy (HRT) Market Forecast by Regions (2018-2025)
Figure North America Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure United States Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Canada Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Mexico Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Europe Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Germany Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure France Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure UK Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Russia Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Italy Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Rest of Europe Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure China Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Japan Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Korea Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure India Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Southeast Asia Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure South America Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Brazil Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Argentina Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Columbia Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Rest of South America Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Saudi Arabia Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure United Arab Emirates Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Egypt Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Nigeria Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure South Africa Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Turkey Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecast (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Forecast by Product (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Market Share Forecast by Product (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Forecast by Product (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Forecast by Route Of Administration (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Forecast by Route Of Administration (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Forecast by Type Of Disease (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Market Share Forecast by Type Of Disease (2018-2025)
Figure Global Hormone Replacement Therapy (HRT) Forecast by Type Of Disease (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*